Literature DB >> 7957525

Availability of synthetic salmon calcitonin in tissue fluid after a single intravenous dose.

E Concia1, M Cruciani, F Bartucci, L Arrigoni, A Longoni.   

Abstract

To obtain further information about the availability of salmon calcitonin in the biophase compartment that surrounds the receptor site, salmon calcitonin concentrations in plasma and skin blister fluid (SBF) after a single i.v. dose of 100 IU synthetic salmon calcitonin were compared in 15 healthy volunteers. Serial blood and SBF samples were collected before and up to 8 h after administration and calcitonin was determined by a specific RIA. The maximum concentration in plasma was 225 pg.ml-1 (in the first sample at 15 min), whereas in SBF the mean peak of 84 pg.ml-1 was reached after about 30 min. The distribution of salmon calcitonin into SBF, defined as the ratio of the AUCs in SBF and plasma, was 1.5. The kinetic profiles of salmon calcitonin in plasma and interstitial fluid were different. Calcitonin in plasma peaked and then levelled out, while in SBF it persisted longer than in plasma. This is the first report of the distribution of salmon calcitonin into blister fluid.

Mesh:

Substances:

Year:  1994        PMID: 7957525     DOI: 10.1007/BF00194408

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  10 in total

1.  Pharmacodynamics of salmon calcitonin in humans: new markers of pharmacological activity.

Authors:  T Di Perri; F Laghi Pasini; P L Capecchi; P Blardi; A L Pasqui; M Franchi; S Mazza; N Sodi; L Domini; L Ceccatelli
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization.

Authors:  G C Nicholson; J M Moseley; P M Sexton; F A Mendelsohn; T J Martin
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

3.  The effect of rectal and nasal administration of salmon calcitonin in normal subjects.

Authors:  T Buclin; J P Randin; A F Jacquet; M Azria; M Attinger; F Gomez; P Burckhardt
Journal:  Calcif Tissue Int       Date:  1987-11       Impact factor: 4.333

4.  Suction skin blister, skin window, and skin chamber techniques to determine extravascular passage of cefotaxime in humans.

Authors:  R F Frongillo; L Galuppo; A Moretti
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

Review 5.  Calcitonin: physiology and pathophysiology.

Authors:  L A Austin; H Heath
Journal:  N Engl J Med       Date:  1981-01-29       Impact factor: 91.245

6.  The influence of protein binding upon tissue fluid levels of six beta-lactam antibiotics.

Authors:  R Wise; A P Gillett; B Cadge; S R Durham; S Baker
Journal:  J Infect Dis       Date:  1980-07       Impact factor: 5.226

7.  Dermo-epidermal separation with suction. Electron microscopic and histochemical study of initial events of blistering on human skin.

Authors:  U Kiistala; K K Mustakallio
Journal:  J Invest Dermatol       Date:  1967-05       Impact factor: 8.551

8.  Calcitonin as a drug.

Authors:  L J Deftos; B P First
Journal:  Ann Intern Med       Date:  1981-08       Impact factor: 25.391

9.  Plasma kinetics and urinary excretion of exogenous human and salmon calcitonin in man.

Authors:  R Huwyler; W Born; E E Ohnhaus; J A Fischer
Journal:  Am J Physiol       Date:  1979-01

10.  Teicoplanin, its pharmacokinetics, blister and peritoneal fluid penetration.

Authors:  R Wise; I A Donovan; C A McNulty; R Waldron; J M Andrews
Journal:  J Hosp Infect       Date:  1986-03       Impact factor: 3.926

  10 in total
  1 in total

Review 1.  Intranasal salcatonin (salmon calcitonin). A review of its pharmacological properties and role in the management of postmenopausal osteoporosis.

Authors:  G L Plosker; D McTavish
Journal:  Drugs Aging       Date:  1996-05       Impact factor: 3.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.